BSEVeerhealth Care Ltd· Pharmaceuticals & BiotechnologyHighPositive
Announced Fri, 15 May, 2026 · 16:58 IST

We wish to inform you that the Company has received a repeat order from one of the leading FMCG Company amounting to Rs. 2.45 Crores

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.8%Reaction day
₹22.14
prior close
₹22.17
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.4%+4.1% vs market
Pharmaceuticals peers, median of 159sector-0.7%+3.5% vs sector

On the reaction day the stock moved 4.1 pts more than Nifty Microcap 250 and 3.5 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+2.0
10m
+1.9
15m
+1.8
30m
+1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.8-1.4+4.1-0.7+3.5
Next day
+4.3-0.9+5.3+0.0+4.3
2d
+5.0-0.3+5.3+0.2+4.8
3d
+6.1+0.8+5.4+1.1+5.0
4d
+6.1+0.9+5.3+0.3+5.8
5d
+8.4+2.5+5.9+1.1+7.3
1w
+8.4+3.1+5.3+1.7+6.7
15d
+10.7+3.5+7.2+1.1+9.6
1m
+30.5+8.0+22.6+2.6+28.0
2m
+85.6+9.3+76.3+8.0+77.7
3m
+116.9+14.0+102.9+8.1+108.8
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 159Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Veerhealth Care Ltd has received a repeat order from one of India's leading FMCG companies for skincare/face care products valued at Rs. 2.45 Crores (245 Lakhs), excluding GST. The order is to be executed within 45 days and is a domestic supply contract. The customer name has not been disclosed due to confidential terms. The company describes it as a significant opportunity and expects additional growth in turnover. This is a repeat order, indicating an existing client relationship rather than a new customer win.

Likely market impact

A positive development for Veerhealth Care, showing steady business from an established FMCG client. The order size appears material relative to the company's likely small scale, and the 45-day execution window suggests near-term revenue recognition. However, without knowing total revenue, the percentage impact cannot be precisely assessed.